Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Wilms Tumor 8Rhabdoid Tumor 7Osteosarcoma 7Neuroblastoma 7Lymphoma, Non-Hodgkin 7Hepatoblastoma 7Sarcoma 6Rhabdomyosarcoma 6Neuroectodermal Tumors, Primitive, Peripheral 6Medulloblastoma 6Histiocytosis, Langerhans-Cell 6Glioma 6Ependymoma 6Central Nervous System Neoplasms 5Sarcoma, Ewing 4Multiple Myeloma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasm Metastasis 3Lung Neoplasms 3Colorectal Neoplasms 3Rectal Neoplasms 2Ovarian Neoplasms 2Neuroendocrine Tumors 2Nasopharyngeal Carcinoma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, B-Cell 2Immunoglobulin Light-chain Amyloidosis 2Endometrial Neoplasms 2Desmoid Tumors 2Carcinoma, Non-Small-Cell Lung 2

Interventions

pembrolizumab 7Nivolumab 7Specimen Handling 6Mitomycin 6Magnetic Resonance Spectroscopy 6Capecitabine 6Radiotherapy 5Fluorouracil 4Drug Therapy 4Biopsy 4Radiation 3Paclitaxel 3Ipilimumab 3Fluorodeoxyglucose F18 3Carboplatin 3dehydroftorafur 2atezolizumab 2aldesleukin 2Tomography, X-Ray Computed 2Sigmoidoscopy 2Radiotherapy, Intensity-Modulated 2Proctoscopy 2Mitozytrex 2Colonoscopy 2CTLA-4 Antigen 2Adoptive Transfer 2trastuzumab deruxtecan 1spartalizumab 1enzalutamide 1entinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anus Neoplasms × Phantoms, Imaging × 1 year × Clear all
NCT03233711 2026-05-29

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer

National Cancer Institute (NCI)

Phase 3 Active not recruiting
344 enrolled
Gastrointestinal

Anal Canal Carcinoma, Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡